Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aurabeat Technology is a Hong Kong-based medical technology company specializing in advanced air purification and disinfection solutions. The company developed the AG+ Antiviral Air Purifier, which is recognized as one of the first to be certified for eliminating over 99.9% of the SARS-CoV-2 virus. Their core technology utilizes silver ion-based filtration to trap and eliminate bacteria and viruses, providing protection in high-traffic environments such as hospitals, schools, and offices. Aurabeat's products are deployed globally and are supported by research from institutions like the University of Hong Kong. The company's portfolio includes portable, commercial, and automotive air filtration systems designed to improve indoor air quality and safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aurabeat Technology.